The share price of Canadian Natural Resources Limited (NYSE:CNQ) fell by 9.63% between December 31, 2025, and January 7, 2026, putting it among the Energy Stocks that Lost the Most This Week. Canadian Natural Resources (CNQ) - Among the Energy Stocks that Fell This Week Canadian Natural Resources Limited (NYSE:CNQ) is a senior crude oil and natural gas producer with ongoing operations in its core areas in Western Canada, the UK portion of the North Sea, and offshore Africa. Canadian Natural Resources Li ...

Group 1: Chevron's Market Position and Outlook - Bernstein raised its price target on Chevron Corporation (CVX) to $172 from $170, maintaining a Market Perform rating, indicating a balanced outlook for oil heading into 2026 with expected near-term volatility but long-term strength [1] - Chevron is the only US oil major operating in Venezuela under a US license that exempts it from sanctions, allowing it to export Venezuelan crude to the US [3] - On January 5, Chevron resumed exports of Venezuelan oil to the US after a four-day pause, becoming the only firm consistently exporting Venezuelan crude [3] Group 2: Industry Context and Developments - An agreement between Caracas and Washington allows up to $2 billion of Venezuelan crude to be exported to the US, which is seen as a key negotiation to redirect supply away from China and help Venezuela avoid deeper production cuts [2] - Chevron's operations in Venezuela are significant as it is currently the only company loading crude for export at key Venezuelan ports [3] - Chevron is involved in various sectors including oil and gas production, fuel and chemical manufacturing, and the development of supporting technologies [4]

Group 1 - The Mosaic Company has entered into a definitive agreement to sell its Potash operation in Carlsbad, New Mexico, for $30 million, which includes operations, assets, and liabilities [1][2] - The sale consists of an initial cash payment of $20 million and deferred cash consideration of $10 million, payable in three equal annual installments starting in 2029, with the transaction expected to close in the first half of 2026 [2] - Following the divestment, the company will concentrate on enhancing potash production in Saskatchewan, Canada, aligning with its strategy to streamline its asset base and focus on higher-return operations [3] Group 2 - Wall Street analysts maintain a consensus Moderate Buy rating for Mosaic, with a price target of $33, indicating a potential upside of 39%, although one analyst has lowered the target to $28, citing pressures from increased exports out of China [4] - The Mosaic Company is recognized as a global leader in crop nutrition, specializing in the mining, production, and distribution of essential fertilizer nutrients like potash and phosphate [5]

Group 1 - Parnassus Investments reported a 5.49% return for the Parnassus Mid Cap Fund in Q3 2025, outperforming the Russell Midcap Index which returned 5.33% [1] - The Russell Mid Cap Index continued to rise following a strong second quarter, indicating a positive market trend [1] Group 2 - Parnassus Core Equity Fund highlighted BILL Holdings, Inc. (NYSE:BILL) as a key investment, noting a one-month return of 16.66% despite a 52-week decline of 45.78% [2] - BILL Holdings, Inc. closed at $51.76 per share on December 03, 2025, with a market capitalization of $5.196 billion [2] - The company is positioned in a large and underpenetrated market for small and medium-sized businesses, with potential for revenue growth as digitization of back-office workflows increases [3] - BILL Holdings benefits from strong distribution partnerships and network effects, providing a competitive advantage in its market [3] Group 3 - BILL Holdings, Inc. was held by 52 hedge fund portfolios at the end of Q3 2025, an increase from 45 in the previous quarter [4] - Despite its potential, some analysts believe that certain AI stocks may offer greater upside potential and lower downside risk compared to BILL Holdings [4]

Group 1: Parnassus Investments Overview - Parnassus Investments released the third-quarter 2025 investor letter for the Parnassus Mid Cap Fund, highlighting a strong performance with a return of 5.49% (net of fees) compared to the Russell Midcap Index's return of 5.33% [1] - The Russell Mid Cap Index continued to rise following a robust second quarter, indicating a positive market trend [1] Group 2: StandardAero, Inc. Insights - StandardAero, Inc. (NYSE:SARO) is highlighted as a key stock in the Parnassus Core Equity Fund's third-quarter 2025 investor letter, focusing on its role as an aerospace engine aftermarket services provider [2][3] - As of January 7, 2026, StandardAero's stock closed at $30.36 per share, with a one-month return of 10.36% and a 52-week gain of 31.77% [2] - StandardAero has a market capitalization of $10.155 billion, indicating its significant presence in the aerospace sector [2] Group 3: Investment Potential of StandardAero, Inc. - The Parnassus Core Equity Fund believes StandardAero has an attractive return profile due to durable demand and potential for margin expansion, driven by factors such as aging fleets and original equipment manufacturer outsourcing [3] - StandardAero's ability to service a variety of aircraft engines positions it as a preferred partner in commercial, military, and business aviation markets, with predictable and nondiscretionary maintenance, repair, and overhaul work [3] Group 4: Hedge Fund Interest and Market Position - StandardAero, Inc. was held by 44 hedge fund portfolios at the end of the third quarter, a decrease from 48 in the previous quarter, indicating fluctuating interest among institutional investors [4] - While StandardAero is recognized for its potential, there is a belief that certain AI stocks may offer greater upside potential with less downside risk, suggesting a competitive investment landscape [4]

Core Insights - Impax Asset Management's "Impax US Sustainable Economy Fund" underperformed the Russell 1000 in Q3 2025, returning 7.33% compared to the index's 7.99% [1] - The fund's strategy focused on lower-risk and high-quality factors, which contributed to its underperformance in a risk-on market environment [1] Company Performance - Elevance Health, Inc. (NYSE:ELV) reported a one-month return of 1.80% and a 52-week decline of 4.32%, with a closing stock price of $366.69 and a market capitalization of $82.571 billion as of January 7, 2026 [2] - Elevance Health's operating revenue for Q3 2025 was $50.1 billion, reflecting a year-over-year increase of 12% [4] Earnings Guidance - Elevance Health's stock experienced a decline due to the company lowering its full-year earnings estimates by over 10% due to increased costs in Medicaid and Affordable Care Act plan channels [3]

Group 1 - Chevron Corporation (NYSE:CVX) has significant interests in Venezuela, currently pumping 100,000 barrels per day from its reserves [1] - Venezuela's total oil production is approximately 900,000 barrels per day, with a majority of exports directed to China [1] - The potential for Chevron to increase its production from Venezuela exists, especially if existing contracts can be renegotiated [1] Group 2 - Chevron is an integrated energy company involved in the exploration, production, refining, and marketing of oil, natural gas, and petrochemical products [2]

Group 1 - Insmed Incorporated (NASDAQ:INSM) is a biopharma company that focuses on developing drugs for rare diseases, achieving a stock performance increase of 152% last year, making it the fifth best performer in the Nasdaq-100 [1] - The company received FDA approval for a treatment targeting non-cystic fibrosis bronchiectasis, which is considered a powerful anti-inflammatory drug [1] - Despite a recent pullback of approximately 18% from its December peak due to disappointing clinical trial results in chronic sinusitis, Insmed remains a company to watch [1] Group 2 - Insmed develops and commercializes therapies for serious and rare diseases, including an approved treatment for complex lung infections and several late and mid-stage clinical programs [2]

Group 1 - Warner Bros. Discovery, Inc. experienced a significant increase of nearly 173% last year, primarily due to a bidding war for the company [1] - The bidding war included a preemptive bid of $83 billion from Netflix, which is considered a major factor in the company's valuation [1] - Paramount Skydance, backed by Oracle's Larry Ellison, also made a higher offer with certain conditions, indicating ongoing competition for the company [1] Group 2 - Warner Bros. Discovery is recognized as a media and entertainment company that creates and distributes movies, TV shows, and streaming content [2] - Despite the potential of Warner Bros. Discovery as an investment, there are opinions suggesting that certain AI stocks may offer greater upside potential and lower downside risk [2]

Core Viewpoint - Occidental Petroleum Corporation has completed the sale of its chemical business, OxyChem, to Berkshire Hathaway for $9.7 billion, marking a strategic move to reduce debt and refocus on its core oil and gas operations [3][4]. Group 1: Sale of OxyChem - The sale of OxyChem was finalized on January 2, 2025, and is part of Occidental's strategy to lower its debt, which increased significantly after a $12 billion acquisition [3]. - The divestment is expected to help Occidental reduce its principal debt balance to below $15 billion, despite the loss of a segment that contributed $595 million in pre-tax income in the first three quarters of 2025 [3][4]. Group 2: Strategic Transformation - Vicki Hollub, President and CEO, emphasized that the sale is a crucial milestone in the company's strategic transformation, aimed at strengthening the balance sheet and enhancing shareholder returns [4]. - Proceeds from the sale will be reinvested into the development of Occidental's oil and gas portfolio, including investments in Permian unconventional assets and other projects [5]. Group 3: Berkshire Hathaway's Stake - Berkshire Hathaway has been a significant investor in Occidental, increasing its stake to nearly 265 million shares, which represents 27% of the company's outstanding shares [6].